Literature DB >> 26662808

A reply to Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2015; doi: 10.1007/s00787-015-0786-1.

Keith Fluegge1.   

Abstract

The author of this correspondence has recently published findings of an ecological investigation wherein herbicide use was proposed as an instrumental variable that predicts healthcare utilization among subjects with severe ADHD impairment via individual exposure to nitrous oxide (N2O) emissions. Vitamin D deficiency, a possible risk factor for autism spectrum disorders (ASD) as discussed by Wang et al., may be a homeostatic response to increasing chronic environmental N2O exposures. The author explains how deficient and insufficient states of vitamin D may promote vagal withdrawal and tolerance to increasing opioid exposures in the environment and how these characteristics are particularly relevant in neurodevelopmental disorders, like ASD and ADHD.

Entities:  

Keywords:  Autism; Nitrous oxide; Vitamin D deficiency

Mesh:

Year:  2015        PMID: 26662808     DOI: 10.1007/s00787-015-0803-4

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  12 in total

1.  The co-occurrence of autism spectrum disorder and attention-deficit/hyperactivity disorder symptoms in parents of children with ASD or ASD with ADHD.

Authors:  Daphne J van Steijn; Jennifer S Richards; Anoek M Oerlemans; Saskia W de Ruiter; Marcel A G van Aken; Barbara Franke; Jan K Buitelaar; Nanda N J Rommelse
Journal:  J Child Psychol Psychiatry       Date:  2012-04-27       Impact factor: 8.982

2.  Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder?

Authors:  Madeeha Kamal; Abdulbari Bener; Mohammad S Ehlayel
Journal:  Atten Defic Hyperact Disord       Date:  2014-03-09

3.  Morphine upregulates kappa-opioid receptors of human lymphocytes.

Authors:  S Suzuki; T K Chuang; L F Chuang; R H Doi; R Y Chuang
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

4.  Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.

Authors:  Bianca Lee Negrao; Priyesh Bipath; Deborah van der Westhuizen; Margaretha Viljoen
Journal:  Neuropsychobiology       Date:  2010-12-18       Impact factor: 2.328

5.  Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.

Authors:  Wei Xiong; Long-Chuan Yu
Journal:  Neurosci Lett       Date:  2006-02-21       Impact factor: 3.046

Review 6.  Vitamin D deficiency: a worldwide problem with health consequences.

Authors:  Michael F Holick; Tai C Chen
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

7.  Pain threshold and morphine activity in vitamin D-deficient rats.

Authors:  C Bazzani; R Arletti; A Bertolini
Journal:  Life Sci       Date:  1984-01-30       Impact factor: 5.037

8.  A study of central opioid receptor involvement in nitrous oxide analgesia in mice.

Authors:  D C Chen; R M Quock
Journal:  Anesth Prog       Date:  1990-07

9.  Autism spectrum disorder and low vitamin D at birth: a sibling control study.

Authors:  Elisabeth Fernell; Susanne Bejerot; Joakim Westerlund; Carmela Miniscalco; Henry Simila; Darryl Eyles; Christopher Gillberg; Mats B Humble
Journal:  Mol Autism       Date:  2015-01-14       Impact factor: 7.509

10.  Glyphosate Use Predicts ADHD Hospital Discharges in the Healthcare Cost and Utilization Project Net (HCUPnet): A Two-Way Fixed-Effects Analysis.

Authors:  Keith R Fluegge; Kyle R Fluegge
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more
  2 in total

Review 1.  Vitamin D Deficiency During Pregnancy and Autism Spectrum Disorders Development.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Front Psychiatry       Date:  2020-01-31       Impact factor: 4.157

2.  A reply to 'Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study'.

Authors:  K Fluegge
Journal:  Transl Psychiatry       Date:  2016-04-26       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.